Fig. 2
From: NAT10 promotes hepatocellular carcinoma progression by modulating the ac4C-DDIAS-PI3K-Akt axis
Knockdown of NAT10 hindered the proliferation, migration, and invasion capabilities of HCC cells in vitro. (A, B) RT-qPCR and Western blotting assays were used to verify NAT10 expression in shNAT10 HCC cells. (C) The CCK8 assay was employed to explore the influence of NAT10 knockdown on the proliferative capacity of HCC cells. (D, E) Transwell assays were conducted to scrutinize the impact of NAT10 knockdown on HCC cell migratory (D) and invasive (E) capacities. Scale bar: 200 μm.
